Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis-Reference-Cited by-同舟云学术

Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis

Published:2012-05-22 Issue:5 Volume:6 Page:e1657
ISSN:1935-2735
Container-title:PLoS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Bhandari Vasundhra,Kulshrestha Arpita,Deep Deepak Kumar,Stark Olivia,Prajapati Vijay Kumar,Ramesh V.,Sundar Shyam,Schonian Gabriele,Dujardin Jean Claude,Salotra Poonam

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference33 articles.

1. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.;PJ Guerin;Lancet Infect Dis,2002

2. Expert Committee on Control of the leishmaniases.,2010

3. A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India.;TK Jha;Am J Trop Med Hyg,2005

4. Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980–2004.;PL Olliaro;Lancet Infect Dis,2005

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimony susceptible Leishmania donovani : evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era;Microbiology Spectrum;2024-06-04

2. Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform;PLOS Neglected Tropical Diseases;2024-04-16

3. Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: a systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform;2023-09-07

4. In vitro miltefosine and amphotericin B susceptibility of strains and clinical isolates of Leishmania species endemic in Brazil that cause tegumentary leishmaniasis;Experimental Parasitology;2023-03

5. Miltefosine Unresponsiveness in Visceral Leishmaniasis;Challenges and Solutions Against Visceral Leishmaniasis;2023